These theoretical assumptions are supported by the results of clinical studies of recombinant IL-2 in patients with immunosuppressive status associated with systemic inflammatory response syndrome caused by sepsis or serious trauma. The gene discussed is IL2; the disease is systemic inflammatory response syndrome.